• Conference Proceeding

Annualized Relapse Rate of First-Line Treatments for Multiple Sclerosis: A Meta-Analysis, Including Indirect Comparisons Versus Fingolimod

Citation

Tyas, D., Roskell, N., Zimovetz, E., Rycroft, C., & Eckert, B. (2012). Annualized Relapse Rate of First-Line Treatments for Multiple Sclerosis: A Meta-Analysis, Including Indirect Comparisons Versus Fingolimod. In [78], p. Meeting Abstract P01136. .

Abstract